• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Genetic and environmental risk factors in Parkinson's disease.

作者信息

Veldman B A, Wijn A M, Knoers N, Praamstra P, Horstink M W

机构信息

Department of Neurology, University Hospital Nijmegen, The Netherlands.

出版信息

Clin Neurol Neurosurg. 1998 Mar;100(1):15-26. doi: 10.1016/s0303-8467(98)00009-2.

DOI:10.1016/s0303-8467(98)00009-2
PMID:9637199
Abstract

Parkinson's disease (PD) is a multifactorial disorder, caused by a combination of age, genetics and environmental factors. Nigral cells are susceptible to multiple causes of derangement of normal cell function, all of which may contribute to the same Parkinson phenotype. Autosomal dominant alpha-synuclein-gene PD represents one of the pure genetic forms, whereas cases of sporadic PD probably depend more on age and environmental factors, MPTP-Parkinsonism being the purest example of an environmentally caused Parkinson phenotype. This review suggests that pesticides-herbicides, smoking and head trauma probably represent the most eligible candidates for environmental factors involved in provoking PD or influencing its natural course.

摘要

相似文献

1
Genetic and environmental risk factors in Parkinson's disease.
Clin Neurol Neurosurg. 1998 Mar;100(1):15-26. doi: 10.1016/s0303-8467(98)00009-2.
2
[Genetics and environmental factors of Parkinson disease].[帕金森病的遗传和环境因素]
Rev Neurol (Paris). 2002 Dec;158 Spec no 1:S11-23.
3
[Epidemiology and causes of Parkinson's disease].[帕金森病的流行病学及病因]
Nervenarzt. 2017 Apr;88(4):345-355. doi: 10.1007/s00115-017-0288-0.
4
Genetics of Parkinson's disease.帕金森病的遗传学
J Neurol. 2001 Oct;248(10):833-40. doi: 10.1007/s004150170066.
5
[Parkinson disease: monogenic forms and genetic susceptibility factors].[帕金森病:单基因形式与遗传易感性因素]
Pathol Biol (Paris). 1998 Nov;46(9):710-2.
6
Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.帕金森病的环境、医学和家族史风险因素:一项基于新英格兰地区的病例对照研究。
Am J Med Genet. 1999 Dec 15;88(6):742-9.
7
Autosomal dominant Parkinson's disease and alpha-synuclein.常染色体显性帕金森病与α-突触核蛋白
Ann Neurol. 1998 Sep;44(3 Suppl 1):S63-4. doi: 10.1002/ana.410440710.
8
The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?环境与帕金森病:黑质纹状体系统是否是神经毒素的优先作用靶点?
Lancet Neurol. 2003 Sep;2(9):531-8. doi: 10.1016/s1474-4422(03)00501-5.
9
Genetics of Parkinsonism: a review.帕金森病的遗传学:综述
Ann Hum Genet. 2001 Mar;65(Pt 2):111-26. doi: 10.1017/S0003480001008557.
10
Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease.与散发性帕金森病患者相比,居住在希腊的α-突触核蛋白帕金森病患者的临床表型。
J Neurol Neurosurg Psychiatry. 2001 May;70(5):662-5. doi: 10.1136/jnnp.70.5.662.

引用本文的文献

1
Zinc-Dependent Modulation of Dopamine Release and Uptake Is Altered in Parkinson's Disease Model Zebrafish.帕金森病模型斑马鱼中锌依赖的多巴胺释放和摄取调节发生改变。
ACS Chem Neurosci. 2025 May 21;16(10):1872-1882. doi: 10.1021/acschemneuro.4c00864. Epub 2025 Apr 30.
2
Glutathione S-transferase polymorphisms (GSTM1/GSTT1) outcomes in clinical profile and treatment responsiveness among Tunisian cohort of Parkinson's disease.突尼斯帕金森病队列中谷胱甘肽S-转移酶基因多态性(GSTM1/GSTT1)与临床特征及治疗反应性的关系
J Neural Transm (Vienna). 2025 Jan;132(1):117-127. doi: 10.1007/s00702-024-02815-w. Epub 2024 Aug 9.
3
Copper-mediated neurotoxicity and genetic vulnerability in the background of neurodegenerative diseases in C. elegans.
铜介导的神经毒性和神经退行性疾病背景下秀丽隐杆线虫的遗传易感性。
Toxicol Sci. 2024 Oct 1;201(2):254-262. doi: 10.1093/toxsci/kfae092.
4
Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond.靶向帕金森病中的半胱氨酸氧化还原蛋白质组:谷胱甘肽前体及其他的作用
Antioxidants (Basel). 2023 Jun 30;12(7):1373. doi: 10.3390/antiox12071373.
5
Genome-wide 5-hydroxymethylcytosine (5hmC) reassigned in Pten-depleted mESCs along neural differentiation.在Pten缺失的小鼠胚胎干细胞向神经分化过程中全基因组5-羟甲基胞嘧啶(5hmC)重新分配。
Front Cell Dev Biol. 2022 Dec 22;10:956604. doi: 10.3389/fcell.2022.956604. eCollection 2022.
6
Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective.揭开神经肽在帕金森病中神经保护作用的神秘面纱:一种新颖而雄辩的治疗视角。
Int J Mol Sci. 2022 Apr 20;23(9):4565. doi: 10.3390/ijms23094565.
7
6-Hydroxydopamine Induces Abnormal Iron Sequestration in BV2 Microglia by Activating Iron Regulatory Protein 1 and Inhibiting Hepcidin Release.6-羟多巴胺通过激活铁调节蛋白 1 和抑制铁调素释放诱导 BV2 小胶质细胞中铁的异常蓄积。
Biomolecules. 2022 Feb 7;12(2):266. doi: 10.3390/biom12020266.
8
-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases.-乙酰半胱氨酸:调节神经退行性疾病中的半胱氨酸氧化还原蛋白质组
Antioxidants (Basel). 2022 Feb 18;11(2):416. doi: 10.3390/antiox11020416.
9
Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity.天然生物碱化合物作为α-突触核蛋白种子纤维形成和毒性的抑制剂。
Molecules. 2021 Jun 19;26(12):3736. doi: 10.3390/molecules26123736.
10
Overview on the Effects of -Acetylcysteine in Neurodegenerative Diseases.乙酰半胱氨酸在神经退行性疾病中的作用概述。
Molecules. 2018 Dec 13;23(12):3305. doi: 10.3390/molecules23123305.